These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 12224690)
1. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. Akay A; Pekcanlar A; Bozdag KE; Altintas L; Karaman A J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):347-52. PubMed ID: 12224690 [TBL] [Abstract][Full Text] [Related]
2. General psychiatric symptoms, quality of sleep, and coping strategies in patients with psoriasis vulgaris. Balta I; Karadag AS; Selek S; Onder S; Kanbay A; Burakgazi-Yilmaz H Int J Dermatol; 2016 Jan; 55(1):60-4. PubMed ID: 25945942 [TBL] [Abstract][Full Text] [Related]
3. Role of depression in quality of life for patients with psoriasis. Schmitt JM; Ford DE Dermatology; 2007; 215(1):17-27. PubMed ID: 17587835 [TBL] [Abstract][Full Text] [Related]
4. Frequency and magnitude of anxiety and depression in patients with psoriasis vulgaris. Nasreen S; Ahmed I; Effendi S J Coll Physicians Surg Pak; 2008 Jul; 18(7):397-400. PubMed ID: 18760060 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Cömert A; Akbaş B; Kılıç EZ; Akın Ö; Gökçe E; Göktuna Z; Taşkapan O Am J Clin Dermatol; 2013 Aug; 14(4):335-42. PubMed ID: 23609607 [TBL] [Abstract][Full Text] [Related]
7. Erectile dysfunction in patients with psoriasis: potential impact of the metabolic syndrome. Tasliyurt T; Bilir Y; Sahin S; Seckin HY; Kaya SU; Sivgin H; Demir AK; Erdemir F Eur Rev Med Pharmacol Sci; 2014; 18(4):581-6. PubMed ID: 24610625 [TBL] [Abstract][Full Text] [Related]
8. Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and Kim SJ; Park MY; Pak K; Han J; Kim GW; Kim HS; Ko HC; Kim MB; Kim BS J Dermatolog Treat; 2018 Dec; 29(8):761-768. PubMed ID: 29658378 [TBL] [Abstract][Full Text] [Related]
9. Psychological health in patients with genital and oral erosive lichen planus. Lundqvist EN; Wahlin YB; Bergdahl M; Bergdahl J J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):661-6. PubMed ID: 16836492 [TBL] [Abstract][Full Text] [Related]
10. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. Devrimci-Ozguven H; Kundakci TN; Kumbasar H; Boyvat A J Eur Acad Dermatol Venereol; 2000 Jul; 14(4):267-71. PubMed ID: 11204514 [TBL] [Abstract][Full Text] [Related]
11. [PAS-positive substances in lichen ruber planus and psoriasis vulgaris]. KONRAD B; RANINCOVA A Cesk Dermatol; 1959 Dec; 34():374-8. PubMed ID: 13752983 [No Abstract] [Full Text] [Related]
12. Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study. Martínez-Ortega JM; Nogueras P; Muñoz-Negro JE; Gutiérrez-Rojas L; González-Domenech P; Gurpegui M J Psychosom Res; 2019 Sep; 124():109780. PubMed ID: 31443809 [TBL] [Abstract][Full Text] [Related]
13. Development of lichen planus and psoriasis on lesions of vitiligo vulgaris. Ujiie H; Sawamura D; Shimizu H Clin Exp Dermatol; 2006 May; 31(3):375-7. PubMed ID: 16681580 [TBL] [Abstract][Full Text] [Related]
14. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Sampogna F; Linder D; Piaserico S; Altomare G; Bortune M; Calzavara-Pinton P; Vedove CD; Girolomoni G; Peserico A; Sala R; Abeni D Acta Derm Venereol; 2014 Jul; 94(4):411-4. PubMed ID: 24287710 [TBL] [Abstract][Full Text] [Related]
15. Associations of the quality of life and psychoemotional state with sociodemographic factors in patients with psoriasis. Petraškienė R; Valiukevičienė S; Macijauskienė J Medicina (Kaunas); 2016; 52(4):238-243. PubMed ID: 27530772 [TBL] [Abstract][Full Text] [Related]
16. Lichen Planus Severity Index: A new, valid scoring system to assess the severity of cutaneous lichen planus. Kaur H; Nikam BP; Jamale VP; Kale MS Indian J Dermatol Venereol Leprol; 2020; 86(2):169-175. PubMed ID: 31898636 [TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053 [TBL] [Abstract][Full Text] [Related]
18. Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Rojo-Moreno JL; Bagán JV; Rojo-Moreno J; Donat JS; Milián MA; Jiménez Y Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Dec; 86(6):687-91. PubMed ID: 9868726 [TBL] [Abstract][Full Text] [Related]
19. Study on the psychological health and related risk factors in 245 patients with psoriasis in Inner Mongolia. Zhang Q; Han J; Zhang Y; Li C; Chen P; Zhang J; Zeng K Psychol Health Med; 2019 Aug; 24(7):769-780. PubMed ID: 30784297 [TBL] [Abstract][Full Text] [Related]
20. The relationship between quality of life and the severity of psoriasis in Turkey. Çakmur H; Derviş E Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]